92 related articles for article (PubMed ID: 21061574)
1. [Increase of immunogenicity of cold-adapted influenza vaccine by using adjuvant].
Markushin SG; Gendon IuZ; Krivtsov GG; Akopova II; Sukhno AS; Pereverzev AD
Zh Mikrobiol Epidemiol Immunobiol; 2010; (5):29-34. PubMed ID: 21061574
[TBL] [Abstract][Full Text] [Related]
2. [COLD-ADAPTED A/KRASNODAR/101/35/59 (H2N2) STRAIN--A PROMISING STRAIN-DONOR OF ATTENUATION FOR PROCURATION OF LIVE INFLUENZA VACCINES].
Markushin SG; Tsfasman TM; Terekhov AV; Lisovskaya KV; Akopova II
Zh Mikrobiol Epidemiol Immunobiol; 2015; (5):27-32. PubMed ID: 26829850
[TBL] [Abstract][Full Text] [Related]
3. [COMPARATIVE STUDY OF IMMUNOGENICITY AND PROTECTIVE EFFECT OF LIVE COLD-ADAPTED AND INACTIVATED VACCINES AGAINST TYPE A INFLUENZA].
Kashirina OS; Chernikova MI; Vasiliev YM
Zh Mikrobiol Epidemiol Immunobiol; 2015; (3):38-46. PubMed ID: 26259268
[TBL] [Abstract][Full Text] [Related]
4. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
[TBL] [Abstract][Full Text] [Related]
5. [Chitosan as an adjuvant for inactivated vaccines against avian influenza viruses].
Gendon IuZ; Vasil'ev IuM; Markushin SG; Akopova II; Koptiaeva IB; Krivtsov GG
Zh Mikrobiol Epidemiol Immunobiol; 2009; (2):40-7. PubMed ID: 19459476
[TBL] [Abstract][Full Text] [Related]
6. Intranasal immunization with live attenuated influenza vaccine plus chitosan as an adjuvant protects mice against homologous and heterologous virus challenge.
Wang X; Zhang W; Liu F; Zheng M; Zheng D; Zhang T; Yi Y; Ding Y; Luo J; Dai C; Wang H; Sun B; Chen Z
Arch Virol; 2012 Aug; 157(8):1451-61. PubMed ID: 22552485
[TBL] [Abstract][Full Text] [Related]
7. A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets.
Joseph T; McAuliffe J; Lu B; Vogel L; Swayne D; Jin H; Kemble G; Subbarao K
Virology; 2008 Aug; 378(1):123-32. PubMed ID: 18585748
[TBL] [Abstract][Full Text] [Related]
8. Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs.
Thomas M; Wang Z; Sreenivasan CC; Hause BM; Gourapura J Renukaradhya ; Li F; Francis DH; Kaushik RS; Khatri M
Vaccine; 2015 Jan; 33(4):542-8. PubMed ID: 25437101
[TBL] [Abstract][Full Text] [Related]
9. [Chitosan as an adjuvant for parenteral inactivated influenza vaccines].
Gendon IuZ; Markushin SG; Krivtsov GG; Akopova II
Vopr Virusol; 2008; 53(5):14-9. PubMed ID: 19069787
[TBL] [Abstract][Full Text] [Related]
10. Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant.
Sui Z; Chen Q; Fang F; Zheng M; Chen Z
Vaccine; 2010 Nov; 28(48):7690-8. PubMed ID: 20870054
[TBL] [Abstract][Full Text] [Related]
11. Alkyl polyglycoside, a highly promising adjuvant in intranasal split influenza vaccines.
Wu H; Bao Y; Wang X; Zhou D; Wu W
Hum Vaccin Immunother; 2017 Jun; 13(6):1-9. PubMed ID: 28129034
[TBL] [Abstract][Full Text] [Related]
12. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
13. [Immunization with live attenuated A/H5N1 vaccine protects guinea pigs from reinfection].
Sergeeva MV; Kuznetsov VV; Kas'ianenko MA; Shaldzhian AA; Repko IA; Potapchuk MV; Romanova IuR; Tsybalova LM
Vopr Virusol; 2013; 58(6):36-9. PubMed ID: 24772645
[TBL] [Abstract][Full Text] [Related]
14. [Production of early cytokines after infection with A/Leningrad/134/57 (H2N2) wide-type virus and cold-adapted attenuated vaccine viruses].
Rekstin AR; Lu K; Kats D; Rudenko LG
Vopr Virusol; 2006; 51(2):27-30. PubMed ID: 16756175
[TBL] [Abstract][Full Text] [Related]
15. An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults.
Talaat KR; Karron RA; Liang PH; McMahon BA; Luke CJ; Thumar B; Chen GL; Min JY; Lamirande EW; Jin H; Coelingh KL; Kemble GW; Subbarao K
Influenza Other Respir Viruses; 2013 Jan; 7(1):66-73. PubMed ID: 22417012
[TBL] [Abstract][Full Text] [Related]
16. Protective efficacy in mice of monovalent and trivalent live attenuated influenza vaccines in the background of cold-adapted A/X-31 and B/Lee/40 donor strains.
Jang YH; Lee EY; Byun YH; Jung EJ; Lee YJ; Lee YH; Lee KH; Lee J; Seong BL
Vaccine; 2014 Jan; 32(5):535-43. PubMed ID: 24342248
[TBL] [Abstract][Full Text] [Related]
17. [New cold-adapted donor strains for live influenza vaccine].
Gendon IuZ; Markushin SG; Tsfasman TM; Akopova II; Akhmatova NK; Koptiaeva IB
Vopr Virusol; 2013; 58(1):11-7. PubMed ID: 23785755
[TBL] [Abstract][Full Text] [Related]
18. A live attenuated equine H3N8 influenza vaccine is highly immunogenic and efficacious in mice and ferrets.
Baz M; Paskel M; Matsuoka Y; Zengel J; Cheng X; Treanor JJ; Jin H; Subbarao K
J Virol; 2015 Feb; 89(3):1652-9. PubMed ID: 25410860
[TBL] [Abstract][Full Text] [Related]
19. Safety, immunogencity, and efficacy of a cold-adapted A/Ann Arbor/6/60 (H2N2) vaccine in mice and ferrets.
Chen GL; Lamirande EW; Jin H; Kemble G; Subbarao K
Virology; 2010 Mar; 398(1):109-14. PubMed ID: 20034647
[TBL] [Abstract][Full Text] [Related]
20. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
